Roche Agenda For 2001 Includes Kytril NDA For Post-Op Use, Pegasys Launch

Roche plans to file an NDA during 2001 for use of the anti-emetic Kytril in post-operative nausea and vomiting, the company said during a recent analysts meeting in Basel.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet